Chennai, Oct 26 : In a groundbreaking development, Naselin, a leading nasal decongestant brand by Cipla Health Limited, today launched its first-of-its-kind Naselin Anti-Viral Nasal Spray with Povidone Iodine to protect against coronavirus and respiratory tract infections.

Research showed that Povidone Iodine can act as the first line of defence against the SARS-CoV-2 virus that causes COVID 19.

With powerful anti-viral properties, the spray is suitable for wide use, especially by the high risk category of essential service workers, according to a release from Cipla.

Povidone Iodine is a trusted molecule with anti-viral, anti-bacterial and anti-fungal properties, which helps to protect from viruses and other germs that cause common upper respiratory tract illnesses like, cold, sinusitis or the flu.

The spray acts by killing the disease causing viruses and bacteria in the nose.

Multiple studies have shown that cells lining the nose are a key entry point for SARS-CoV-2. The use of topical antiviral drugs at the nasal region is essential for preventive–care.

The Naselin Anti-Viral Spray ensures its relevance beyond the current COVID context to any other respiratory tract discomfort.

The 15ml spray bottle is priced at Rs. 99 and is available across 700 Apollo and Medplus pharmacies in Maharashtra, Andhra Pradesh and Telangana as well as online e-commerce platforms such as 1mg, Pharmeasy.(UNI)